IT1158026B - Prodotto coadiuvante per la profilassi e la terapia del cancro del seno, dopo mastectomia, costituito esclusivamente da un 17alfa-acilossi-6-metilpregna-4,6-diene-3,20-dione - Google Patents
Prodotto coadiuvante per la profilassi e la terapia del cancro del seno, dopo mastectomia, costituito esclusivamente da un 17alfa-acilossi-6-metilpregna-4,6-diene-3,20-dioneInfo
- Publication number
- IT1158026B IT1158026B IT49368/82A IT4936882A IT1158026B IT 1158026 B IT1158026 B IT 1158026B IT 49368/82 A IT49368/82 A IT 49368/82A IT 4936882 A IT4936882 A IT 4936882A IT 1158026 B IT1158026 B IT 1158026B
- Authority
- IT
- Italy
- Prior art keywords
- breast cancer
- given
- mastectomy
- prevention
- cancer recurrence
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- CKNOLMVLQUPVMU-XOMFLMSUSA-N Digitalin Natural products O(C)[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@@H]([C@H](O)C5)C5=CC(=O)OC5)CC4)CC3)CC2)[C@@H]1O CKNOLMVLQUPVMU-XOMFLMSUSA-N 0.000 abstract 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- CPFNIKYEDJFRAT-UHFFFAOYSA-N Strospasid Natural products OC1C(OC)C(O)C(C)OC1OC1CC(CCC2C3(CC(O)C(C3(C)CCC32)C=2COC(=O)C=2)O)C3(C)CC1 CPFNIKYEDJFRAT-UHFFFAOYSA-N 0.000 abstract 1
- CKNOLMVLQUPVMU-UHFFFAOYSA-N UNPD183315 Natural products O1C(C)C(OC2C(C(O)C(O)C(CO)O2)O)C(OC)C(O)C1OC(C1)CCC2(C)C1CCC(C1(CC3O)O)C2CCC1(C)C3C1=CC(=O)OC1 CKNOLMVLQUPVMU-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 230000005540 biological transmission Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- CKNOLMVLQUPVMU-YMMLYESFSA-N digitalin Chemical compound C1([C@@H]2[C@@]3(C)CC[C@H]4[C@H]([C@]3(C[C@@H]2O)O)CC[C@H]2[C@]4(C)CC[C@@H](C2)O[C@H]2[C@H](O)[C@H]([C@H]([C@@H](C)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)OC)=CC(=O)OC1 CKNOLMVLQUPVMU-YMMLYESFSA-N 0.000 abstract 1
- 229950004590 digitalin Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT49368/82A IT1158026B (it) | 1982-10-26 | 1982-10-26 | Prodotto coadiuvante per la profilassi e la terapia del cancro del seno, dopo mastectomia, costituito esclusivamente da un 17alfa-acilossi-6-metilpregna-4,6-diene-3,20-dione |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT49368/82A IT1158026B (it) | 1982-10-26 | 1982-10-26 | Prodotto coadiuvante per la profilassi e la terapia del cancro del seno, dopo mastectomia, costituito esclusivamente da un 17alfa-acilossi-6-metilpregna-4,6-diene-3,20-dione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8249368A0 IT8249368A0 (it) | 1982-10-26 |
| IT1158026B true IT1158026B (it) | 1987-02-18 |
Family
ID=11270485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT49368/82A IT1158026B (it) | 1982-10-26 | 1982-10-26 | Prodotto coadiuvante per la profilassi e la terapia del cancro del seno, dopo mastectomia, costituito esclusivamente da un 17alfa-acilossi-6-metilpregna-4,6-diene-3,20-dione |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1158026B (it) |
-
1982
- 1982-10-26 IT IT49368/82A patent/IT1158026B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| IT8249368A0 (it) | 1982-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2040914A1 (en) | Treatment of erectile dysfunction | |
| MY106528A (en) | Method of treating impotence. | |
| ES2136618T3 (es) | Cicatrizacion de heridas. | |
| EG18583A (en) | Compositions and methods of effecting contraception | |
| EP0612248A4 (en) | Combination chemotherapy. | |
| EP0373744A3 (en) | Use of nalmefene or naltrexone in the treatment of autoimmune diseases | |
| EP0377272A3 (en) | Use of nalmefene or naltrexone in the manufacture of a medicament for the treatment of inflammation in an arthritic disease or associated inflammatory diseases | |
| EP0136011A3 (en) | A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor | |
| HU9402914D0 (en) | Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent | |
| NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
| JPS5735516A (en) | Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation | |
| GR3031129T3 (en) | Enhancement of glutathione levels with glutamine | |
| MY121623A (en) | Methods of preventing breast cancer. | |
| EP0324802A4 (en) | Method for the treatment of body tissues and the administration of drugs thereto | |
| EP0313654A4 (en) | MEDICINAL PRODUCTS FOR PROPHYLAXIS AND TREATMENT OF LIVER DISEASES. | |
| BE894860A (fr) | Therapeutique adjuvante par agent progestatif | |
| EP0369216A3 (en) | Pharmaceutical preparation based on ester derivatives of hecogenine, and their use in treating benign prostatic hyperplasia | |
| IT1158026B (it) | Prodotto coadiuvante per la profilassi e la terapia del cancro del seno, dopo mastectomia, costituito esclusivamente da un 17alfa-acilossi-6-metilpregna-4,6-diene-3,20-dione | |
| EP0476711A3 (en) | Use of 5-fluorouracil for the treatment of AIDS | |
| JPS57106618A (en) | Anticancer agent consisting of polyprenyl compound | |
| JPS5793913A (en) | Enhancing agent for spermous vital power | |
| DE3163920D1 (en) | Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases | |
| AU4042795A (en) | Treatment of non-small cell lung carcinoma | |
| JPS55113721A (en) | Immunity regulator | |
| ES2153828T3 (es) | Composiciones que contienen insulina y amilina para el tratamiento de mamiferos deficientes en insulina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19971030 |